"The Real-World Medicare Costs of Alzheimer Disease: Considerations for Policy and Care" findings published in the July issue of Journal of Managed Care and Specialty Pharmacy, demonstrate the importance of better diagnosis, treatment, and care of individuals with Alzheimer's, which could lead to more favorable patient outcomes and improved costs for state Medicaid programs and caregivers.
News you can use: health & drug safety updates
June 25, 2019
Alliance for Aging Research Study Finds That Alzheimer's Disease Is Not Bankrupting Medicare, But It Is Taking a Huge Toll on State Medicaid Programs and Family Caregivers
June 12, 2019
New Resource on Parkinson's Provides a Comprehensive Look at the Human and Economic Burden of the Disease
The Alliance for Aging Research released The Silver Book®—: Parkinson's Disease factsheet at a Capitol Hill briefing with The Michael J. Fox Foundation for Parkinson's Research. The new resource highlights leading statistics about the disease that affects close to one million Americans, including data on the toll of the disease and the value of innovation and public policy solutions in reducing its impact.
June 5, 2019
A nationwide benchmark survey conducted by the Consumer Healthcare Products Association (CHPA) Educational Foundation shows that consumer awareness of how to use products containing acetaminophen safely and effectively, while avoiding the risks of accidental overdose and liver damage, remains high. BeMedWise is a member of the Acetaminophen Awareness Coalition which sponsors the Know Your Dose educational campaign.
May 30, 2019
The Pain Management Best Practices Inter-Agency Task Force, a federal advisory committee established by the Comprehensive Addiction and Recovery Act of 2016, released its final report on acute and chronic pain management best practices, calling for a balanced, individualized, patient-centered approach.
May 28, 2019
Opioid prescriptions were written at nearly 57 million visits to doctors' offices between 2005 and 2015 according to a study published in Pediatrics. The study found the drugs are often prescribed to teenagers and young adults for tooth and back pain. HealthDay.
May 28, 2019
More than 3.4 million (3%) Americans aged 40 years and older are either legally blind (having visual acuity [VA] of 20/200 or worse or a visual field of less than 20 degrees) or are visually impaired (having VA of 20/40 or less).
May 21, 2019
A study in the Journal of General Internal Medicine says physicians were as likely to accurately estimate patients' adherence to medication from their descriptions of their medicine routines as by patients' direct reports of missed medication. A visit to the doctor's office typically begins with a series of questions, including one about medications. An Iowa State University researcher recommends doctors ask a follow up to that question to make sure patients are taking their medications as prescribed.
May 17, 2019
Today, the U.S. Food and Drug Administration is warning patients and health care professionals of risks associated with the use of unapproved or unauthorized devices for diabetes management, including continuous glucose monitoring systems, insulin pumps and automated insulin dosing systems. In the safety communication issued today, the agency noted that the use of unapproved or unauthorized devices could result in inaccurate blood glucose (sugar) measurements or unsafe insulin dosing, which can lead to injury requiring medical intervention or even death.
April 30, 2019
FDA requires stronger warnings about rare but serious incidents related to certain prescription insomnia medicines
The U.S. Food and Drug Administration announced the agency is requiring a new boxed warning – the agency’s most prominent warning – on certain prescription insomnia drugs to better ensure patients and their health care professionals have the information they need when considering use of these medicines. The boxed warning follows several reports of rare, but serious injuries and deaths resulting from various complex sleep behaviors after taking these medicines.
April 25, 2019
FDA launches public education campaign to encourage safe removal of unused opioid pain medicines from homes
The U.S. Food and Drug Administration today announced the launch of a new education campaign, "Remove the Risk" to help Americans understand the important role they play in removing and properly disposing of unused prescription opioids from their homes. Visit www.fda.gov/DrugDisposal and www.FDA.gov/RemovetheRisk and download fact sheets, social media and more. BeMedWise resources include: Safe medicine storage & disposal and Safe Disposal: An Important Part of Addressing Opioid Abuse.